IGF2BP3 Associates with Proliferative Phenotype and Prognostic Features in B-Cell Acute Lymphoblastic Leukemia
Mäkinen, A., Nikkilä, A., Haapaniemi, T., Oksa, L., Mehtonen, J., Vänskä, M., Heinäniemi, M., Paavonen, T., & Lohi, O. (2021). IGF2BP3 Associates with Proliferative Phenotype and Prognostic Features in B-Cell Acute Lymphoblastic Leukemia. Cancers, 13(7), Article 1505. https://doi.org/10.3390/cancers13071505
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
The oncofetal protein insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) belongs to a family of RNA-binding proteins involved in localization, stability, and translational regulation of target RNAs. IGF2BP3 is used as a diagnostic and prognostic marker in several malignancies. Although the prognosis of pediatric B-cell acute lymphoblastic leukemia (B-ALL) has improved, a subgroup of patients exhibits high-risk features and suffer from disease recurrence. We sought to identify additional biomarkers to improve diagnostics, and we assessed expression of IGF2BP3 in a population-based pediatric cohort of B-ALL using a tissue microarray platform. The majority of pediatric B-ALL cases were positive for IGF2BP3 immunohistochemistry and were associated with an increased proliferative phenotype and activated STAT5 signaling pathway. Two large gene expression data sets were probed for the expression of IGF2BP3—the highest levels were seen among the B-cell lymphomas of a germinal center origin and well-established (KMT2A-rearranged and ETV6-RUNX1) and novel subtypes of B-ALL (e.g., NUTM1 and ETV6-RUNX1-like). A high mRNA for IGF2BP3 was associated with a proliferative “metagene” signature and a high expression of CDK6 in B-ALL. A low expression portended inferior survival in a high-risk cohort of pediatric B-ALL. Overall, our results show that IGF2BP3 shows subtype-specificity in expression and provides prognostic utility in high-risk B-ALL. ...
Dataset(s) related to the publication
Publication in research information system
MetadataShow full item record
Additional information about fundingThe work was supported by the Competitive State Research Financing of the Expert Responsibility at Tampere University Hospital (9X027) and by grants from the Academy of Finland (No. 277816 and No. 310106, O.L.), Sigrid Juselius Foundation (M.H. and O.L.), the Cancer Society of Finland (M.H. and O.L.), the Jane and Aatos Erkko Foundation (O.L. and M.H.), and the Väre Foundation for Paediatric Cancer Research (A.M.). ...
Showing items with similar title or keywords.
The expression and prognostic relevance of programmed cell death protein 1 in tongue squamous cell carcinoma Tervo, Sanni; Seppälä, Miia; Rautiainen, Markus; Huhtala, Heini; Salo, Tuula; Al‐Samadi, Ahmed; Kuopio, Teijo; Ahtiainen, Maarit; Tommola, Satu; Paavonen, Timo; Toppila‐Salmi, Sanna (Wiley-Blackwell, 2020)Background Programmed cell death protein 1 (PD‐1) is an immune checkpoint receptor which plays an important role in a patient´s immune responses to microbial and cancer antigens. It is expressed in tumor infiltrating ...
Prognostic Value of Immune Environment Analysis in Small Bowel Adenocarcinomas with Verified Mutational Landscape and Predisposing Conditions Wirta, Erkki-Ville; Szeto, Säde; Hänninen, Ulrika; Ahtiainen, Maarit; Böhm, Jan; Mecklin, Jukka-Pekka; Aaltonen, Lauri A.; Seppälä, Toni T. (MDPI, 2020)Background: Small bowel adenocarcinoma (SBA) is a rare yet insidious cancer with poor survival. The abundance of tumour-infiltrating lymphocytes is associated with improved survival, but the role of the programmed ...
Stromal hyaluronan accumulation is associated with low immune response and poor prognosis in pancreatic cancer Tahkola, Kyösti; Ahtiainen, Maarit; Mecklin, Jukka-Pekka; Kellokumpu, Ilmo; Laukkarinen, Johanna; Tammi, Markku; Tammi, Raija; Väyrynen, Juha P.; Böhm, Jan (Nature Publishing Group, 2021)Hyaluronan (HA) accumulation has been associated with poor survival in various cancers, but the mechanisms for this phenomenon are still unclear. The aim of this study was to investigate the prognostic significance of ...
Prognostic impact of CD73 expression and its relationship to PD-L1 in patients with radically treated pancreatic cancer Tahkola, Kyösti; Ahtiainen, Maarit; Kellokumpu, Ilmo; Mecklin, Jukka-Pekka; Laukkarinen Johanna; Laakkonen, Joni; Kenessey, Istvan; Jalkanen, Sirpa; Salmi, Marko; Böhm, Jan (Springer, 2021)Immune suppressing molecule CD73 is overexpressed in various cancers and associated with poor survival. Little is so far known about the predictive value of CD73 in pancreatic ductal adenocarcinoma (PDAC). The purpose of ...
Repo, Heli; Gurvits, Natalia; Löyttyniemi, Eliisa; Nykänen, Marjukka; Lintunen, Minnamaija; Karra, Henna; Kurki, Samu; Kuopio, Teijo; Talvinen, Kati; Söderström, Mirva; Kronqvist, Pauliina (BioMed Central, 2017)Background: PTTG1-interacting protein (PTTG1IP) is an oncogenic protein, which participates in metaphase-anaphase transition of the cell cycle through activation of securin (PTTG1). PTTG1IP promotes the shift of securin ...